These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1518837)

  • 121. Sutimlimab: First Approval.
    Dhillon S
    Drugs; 2022 May; 82(7):817-823. PubMed ID: 35412113
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in
    Omoyinmi E; Mohamoud I; Gilmour K; Brogan PA; Eleftheriou D
    Front Immunol; 2018; 9():2524. PubMed ID: 30443255
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Molecular aspects of C3 interactions and structural/functional analysis of C3 from different species.
    Becherer JD; Alsenz J; Lambris JD
    Curr Top Microbiol Immunol; 1990; 153():45-72. PubMed ID: 2404697
    [No Abstract]   [Full Text] [Related]  

  • 124. Species specificity of the complement inhibitor compstatin investigated by all-atom molecular dynamics simulations.
    Tamamis P; Morikis D; Floudas CA; Archontis G
    Proteins; 2010 Sep; 78(12):2655-67. PubMed ID: 20589629
    [TBL] [Abstract][Full Text] [Related]  

  • 125. An equilibrium model of the metastable binding sites of alpha 2-macroglobulin and complement proteins C3 and C4.
    Khan SA; Erickson BW
    J Biol Chem; 1982 Oct; 257(20):11864-7. PubMed ID: 6181062
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Intrinsic chemical reactivity of activated human complement component C3: A historical glimpse into research during 1979-1980 on the covalent binding properties of C3, C4 and alpha-2 macroglobulin.
    Sim R; Twose TM; Sim E; Reid KBM
    Immunobiology; 2022 Jul; 227(4):152209. PubMed ID: 35841752
    [No Abstract]   [Full Text] [Related]  

  • 127. Nucleotide and deduced amino acid sequence of rat complement C3.
    Misumi Y; Sohda M; Ikehara Y
    Nucleic Acids Res; 1990 Apr; 18(8):2178. PubMed ID: 2336397
    [No Abstract]   [Full Text] [Related]  

  • 128. Pulmonary artery catheter introducers: do the component parts affect flow rate?
    Hyman SA; Smith DW; England R; Naukam R; Berman ML
    Anesth Analg; 1991 Nov; 73(5):573-5. PubMed ID: 1952137
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Molecular modelling of C3 and its ligands.
    Sim RB; Perkins SJ
    Curr Top Microbiol Immunol; 1990; 153():209-22. PubMed ID: 2404695
    [No Abstract]   [Full Text] [Related]  

  • 130. Biosynthesis of cyclopentenylglycine from α-ketopimelate in Idesia polycarpa callus cultures.
    Tober I; Spener F
    Plant Cell Rep; 1982 Oct; 1(5):193-6. PubMed ID: 24257705
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease.
    Ogata RT; Low PJ
    J Immunol; 1995 Sep; 155(5):2642-51. PubMed ID: 7650393
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Substrate specificities of the protease of mouse serum Ra-reactive factor.
    Ogata RT; Low PJ; Kawakami M
    J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
    Sandoval A; Ai R; Ostresh JM; Ogata RT
    J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
    [TBL] [Abstract][Full Text] [Related]  

  • 134. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
    Vorup-Jensen T; Jensenius JC; Thiel S
    Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Mutants of complement component C3 cleaved by the C4-specific C1-s protease.
    Mathias P; Carrillo CJ; Zepf NE; Cooper NR; Ogata RT
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8125-9. PubMed ID: 1518837
    [TBL] [Abstract][Full Text] [Related]  

  • 136. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
    Isenman DE; Podack ER; Cooper NR
    J Immunol; 1980 Jan; 124(1):326-31. PubMed ID: 7350230
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Structural and functional characterization of an incompletely processed form of murine C4 and Slp.
    Karp DR; Capra JD; Atkinson JP; Shreffler DC
    J Immunol; 1982 May; 128(5):2336-41. PubMed ID: 7061863
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Structure of murine complement component C3. I. Nucleotide sequence of cloned complementary and genomic DNA coding for the beta chain.
    Lundwall A; Wetsel RA; Domdey H; Tack BF; Fey GH
    J Biol Chem; 1984 Nov; 259(22):13851-6. PubMed ID: 6548745
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The structural basis of the multiple forms of human complement component C4.
    Belt KT; Carroll MC; Porter RR
    Cell; 1984 Apr; 36(4):907-14. PubMed ID: 6546707
    [TBL] [Abstract][Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.